Cirugía de la Obesidad y de la Diabetes. Tratamiento médico de la obesidad. Bypass Gástrico, Gastrectomía Tubular, Balón Gástrico, cirugía plástica tras obesidad
Cirugía de la Obesidad y de la Diabetes. Tratamiento médico de la obesidad. Bypass Gástrico, Gastrectomía Tubular, Balón Gástrico, cirugía plástica tras obesidad
"18 645 patients with a total cholesterol of 6·5 mmol/L or greater were recruited from local physicians throughout Japan between 1996 and 1999. Patients were randomly assigned to receive either 1800 mg of EPA daily with statin (EPA group; n=9326) or statin only (controls; n=9319) with a 5-year follow-up. The primary endpoint was any major coronary event, including sudden cardiac death, fatal and non-fatal myocardial infarction, and other non-fatal events including unstable angina pectoris, angioplasty, stenting, or coronary artery bypass grafting. Analysis was by intention-to-treat.
Findings
At mean follow-up of 4·6 years, we detected the primary endpoint in 262 (2·8%) patients in the EPA group and 324 (3·5%) in controls-a 19% relative reduction in major coronary events (p=0·011). Post-treatment LDL cholesterol concentrations decreased 25%, from 4·7 mmol/L in both groups. Serum LDL cholesterol was not a significant factor in a reduction of risk for major coronary events. Unstable angina and non-fatal coronary events were also significantly reduced in the EPA group. Sudden cardiac death and coronary death did not differ between groups. In patients with a history of coronary artery disease who were given EPA treatment, major coronary events were reduced by 19% (secondary prevention subgroup: 158 [8·7%] in the EPA group vs 197 [10·7%] in the control group; p=0·048). In patients with no history of coronary artery disease, EPA treatment reduced major coronary events by 18%, but this finding was not significant (104 [1·4%] in the EPA group vs 127 [1·7%] in the control group; p=0·132)."
"The Japan eicosapentaenoic acid (EPA) Lipid Intervention Study (JELIS) is a clinical trial that all Track Your Plaquers should know about.
This enormous trial followed a simple design:
Japanese men, between 40-75 years, and Japanese postmenopausal women aged
Can America bypass the drive-thru window and make dinner for $5 per person? That's the question Slow Food USA asked last month when it kicked off its $5 Challenge, a nationwide call to action to return to the kitchen, and in the words of the group's president Josh Viertel, "take back the 'Value Meal.'"